Fair Value Calculator Fair Value Calculator
EN DE

RAP (RAP) Fair Value & Analysis

IN · Market cap ₹211M

R RAP RAP · BSE
Price₹35.92
Fair Value₹53.72
Upside+49.6%
Quality68/100
Watch RAP for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹34.19 – ₹68.29

Fair value as of: Jul 5, 2026

From 24 valuation models · updated today

Share price −9.9% over the past month.

Price vs Fair Value (12 months)

₹47.14 ₹24.53 Fair Value ₹53.72 Jul 2025 Jul 2026

12‑month range ₹24.53 – ₹47.14 · fair‑value band ₹34.19 – ₹68.29 · the ₹35.92 price screens below the ₹53.72 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

RAP (RAP) currently trades at ₹35.92, while our model-based Fair Value estimate is ₹53.72 — implying the stock looks roughly 49.6% undervalued today. We read business quality at 68/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, RAP generated revenue of ₹678M at a net margin of 64.6%. It earns a return on equity of 144.7%. Net debt stands at ₹430M. The stock trades on a trailing P/E of 0.5. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹34.19 (bear case) to ₹68.29 (bull case); at ₹35.92, the current price sits within that range. The share trades about 27% below its 52-week high and 53% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹678M
Net margin 64.6%
Return on equity 145%
Free cash flow ₹39.6M FY2025
P/E ratio 0.5
Operating margin -27.9%
More key figures
EPS (TTM) ₹74.53
Net debt ₹430M FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

RAP reported revenue of ₹678M in FY2025 versus −₹672K in FY2021. Reported net income was ₹438M in FY2025.

Revenue
FY21 −₹672K
FY22 ₹0
FY23 ₹0
FY24 ₹0
FY25 ₹678M
Net income
FY21 −₹9.5M
FY22 −₹8.3M
FY23 −₹7.9M
FY24 −₹16.2M
FY25 ₹438M

Is RAP fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "RAP Fair Value". https://www.fairvalue-calculator.com/stock/RAP

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is RAP (RAP) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹53.72 versus a price of ₹35.92 — about +50% (undervalued). Model-based estimate, not financial advice.
What is the fair value of RAP?
Our model-based fair value for RAP is ₹53.72 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹35.92.
What is the quality score of RAP?
RAP has a Quality Score of 68/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of RAP (RAP)?
RAP reported trailing-twelve-month revenue of about ₹678M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of RAP?
The net profit margin of RAP is about 64.6%, meaning it keeps roughly 64.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.